Abstract
Background: Primary tracheal adenoid cystic carcinoma is a rare, slow-growing pulmonary malignancy. Due to the low incidence, clinicians are unable to diagnose and treat such disease, which is prone to cause misdiagnosis or missed diagnosis, consequently leading to delayed treatment.
Case Presentation: Here, we reported a case of a 72-year-old woman who was diagnosed as primary bronchial adenoid cystic carcinoma after three years. At the time of the final diagnosis, lesion involvement was seen in the entire bronchus, and radical treatment was not available.
Conclusions: Endoscopic bronchoscopy and palliative radiotherapy can relieve the symptoms of the patient and make the patient survive with the tumor for a long time.
Keywords: Tracheal adenoid cystic carcinoma, pulmonary malignancy, tumor, survive, cough, radiotherapy.
Graphical Abstract
Current Bioinformatics
Title:Continual Cough: Experience and Lessons from a Case of Bronchial Adenoid Cystic Carcinoma
Volume: 16 Issue: 4
Author(s): Lin Sheng, Junwei Tu, Yijun Sheng, Jingqian Zhu, Huijun Chen, Jianghua Tian, Lixia Wang and Chuli Pan*
Affiliation:
- Department of Respiratory Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang,China
Keywords: Tracheal adenoid cystic carcinoma, pulmonary malignancy, tumor, survive, cough, radiotherapy.
Abstract:
Background: Primary tracheal adenoid cystic carcinoma is a rare, slow-growing pulmonary malignancy. Due to the low incidence, clinicians are unable to diagnose and treat such disease, which is prone to cause misdiagnosis or missed diagnosis, consequently leading to delayed treatment.
Case Presentation: Here, we reported a case of a 72-year-old woman who was diagnosed as primary bronchial adenoid cystic carcinoma after three years. At the time of the final diagnosis, lesion involvement was seen in the entire bronchus, and radical treatment was not available.
Conclusions: Endoscopic bronchoscopy and palliative radiotherapy can relieve the symptoms of the patient and make the patient survive with the tumor for a long time.
Export Options
About this article
Cite this article as:
Sheng Lin , Tu Junwei , Sheng Yijun , Zhu Jingqian , Chen Huijun , Tian Jianghua , Wang Lixia and Pan Chuli *, Continual Cough: Experience and Lessons from a Case of Bronchial Adenoid Cystic Carcinoma, Current Bioinformatics 2021; 16 (4) . https://dx.doi.org/10.2174/1574893615666200831170923
DOI https://dx.doi.org/10.2174/1574893615666200831170923 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies
Clinical Cancer Drugs Lung Cancer Chemotherapy, New Treatment and Related Patents
Recent Patents on Anti-Cancer Drug Discovery Advances in Liver-Directed Gene Therapy for Hepatocellular Carcinoma by Non-Viral Delivery Systems
Current Gene Therapy Robust Pulmonary Nodule Segmentation in CT Image for Juxta-pleural and Juxta-vascular Case
Current Bioinformatics Strategies for Preparing Different Types of Lipid Polymer Hybrid Nanoparticles in Targeted Tumor Therapy
Current Pharmaceutical Design Synthesis and Single-Crystal X-Ray Diffraction Studies of an Arylidenethiosemicarbazone and Hydrazonyl-phenylthiazole
Letters in Organic Chemistry New Perspectives in the Pharmacological Potential of Naringin in Medicine
Current Medicinal Chemistry Cancer Therapy: Targeting Cell Cycle Regulators
Anti-Cancer Agents in Medicinal Chemistry Technetium Labeled Small Peptide Radiopharmaceuticals in the Identification of Lung Cancer
Current Pharmaceutical Design Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Current Stem Cell Research & Therapy HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors-Considerations for Successful Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Current Pharmaceutical Design Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Advances in Chemotherapy and Targeted Systemic Therapies for Urothelial Cancer
Current Drug Therapy Anticancer Activity and DNA Binding of 4-Alkylenediamines Modified Naphthalimide Derivatives
Letters in Drug Design & Discovery Late Life Depression: A Diagnostic and Pharmacological Review
Current Psychopharmacology Clinical Pharmacokinetics of Systemically Administered Antimycotics
Current Clinical Pharmacology Use of the Bradykinin Agonist, Cereport as a Pharmacological Means of Increasing Drug Delivery to the CNS
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Chemical and Biological Aspects of the Natural 1,4-Benzoquinone Embelin and its (semi-)Synthetic Derivatives
Current Medicinal Chemistry Neuronal Generation from Somatic Stem Cells: Current Knowledge and Perspectives on the Treatment of Acquired and Degenerative Central Nervous System Disorders
Current Gene Therapy